Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2691041000168112 | Seretide MDI 50/25 inhalation, 120 actuations | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 2691051000168114 | Seretide MDI 50/25 (fluticasone propionate 50 microgram / 1 actuation + salmeterol 25 microgram / 1 actuation) inhalation, 120 actuations (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Seretide MDI 50/25 inhalation, 120 actuations | Is a | trade product pack | true | Inferred relationship | Some | ||
| Seretide MDI 50/25 inhalation, 120 actuations | Is a | fluticasone propionate 50 microgram/actuation + salmeterol 25 microgram/actuation inhalation, 120 actuations | true | Inferred relationship | Some | ||
| Seretide MDI 50/25 inhalation, 120 actuations | has TPUU | Seretide MDI 50/25 inhalation, actuation | true | Inferred relationship | Some | 1 | |
| Seretide MDI 50/25 inhalation, 120 actuations | has TP | Seretide MDI 50/25 | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Seretide MDI 50/25 (fluticasone propionate 50 microgram / 1 actuation + salmeterol 25 microgram / 1 actuation) inhalation, 120 actuations, aerosol can (containered trade product pack) | Is a | True | Seretide MDI 50/25 inhalation, 120 actuations | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR